Arcinova have established expertise and technologies that are routinely applied to the understanding of active pharmaceutical ingredients (APIs), how best to formulate them for clinical and non-clinical applications, what their stability characteristics are and how to manufacture the formulations of choice reproducibly.
Formulation development programs can be conducted in isolation but are most powerful when combined with some or all of the synthetic, analytical, microbiological, clinical product manufacturing and regulatory CMC expertise available within Arcinova.
Our range of services related to drug product include:
• Materials science and spectroscopic investigations
• Non-clinical formulation development (oral and IV)
• Clinical formulation development (oral and IV)
• Stability testing
• Clinical Product Manufacture (oral and IV)
• Clinical product manufacture (Cytotoxic/high potency/radiolabelled products)
• QC testing and QP release
CPhI WorldwideCPhI Worldwide will be attended by Nathalie Huther, Business Development Manager Europe. Nathalie will be located at the DIT stand: 9J40
CPhI WorldwideDates: 9th - 11th SeptemberLocation: Madrid, Spain
Nordic Life Science DaysNordic Life Science Days annual conference will be attended by Nathalie Huther, Business Development Manager Europe.
Nordic Life Science DaysDates: 10th - 12th SeptemberLocation: Stockholm, Sweden
PHSS & UCL Q3P Annual ConferencePHSS & UCL Q3P Annual Conference will be attended by Angela Fuller, Microbology Team Leader.
PHSS & UCL Q3P Annual ConferenceDates: 11th SeptemberLocation: UCL, London